Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mirati Therapeutics (DE:26M)
FRANKFURT:26M
Mirati Therapeutics (26M) Ownership - Who Owns Mirati Therapeutics?
0 Followers
Mirati Therapeutics (26M) Ownership Overview
0.00% Insiders
0.00% Mutual Funds
0.49% Other Institutional Investors
99.51% Public Companies and
Individual Investors
The ownership structure of Mirati Therapeutics (DE:26M) stock is a mix of institutional, retail and individual investors. Approximately 0.49% of the company’s stock is owned by Institutional Investors, 0.00% is owned by Insiders and 99.51% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jan 18, 2024 | Benjamin Hickey Evp & Cco | Sold | $94255 |
| Jan 18, 2024 | Jamie Christensen Evp & Chief Scientific Officer | Sold | $94255 |
| Jan 09, 2024 | Benjamin Hickey Evp & Cco | Sold | $123143 |
| Jan 09, 2024 | Benjamin Hickey Chief Commercial Officer | Sold | $123143 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2023 | Bought | $466440 | |
| Sep 30, 2023 | Sold | $12119393 | |
| Sep 30, 2023 | Bought | $43603560 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,267,000 | Insider | ― | 67,531,100 | |
| 6,672,789 | Insider | ― | 355,659,654 | |
| 5,731 | Insider | ― | 305,462 | |
| 39,401 | Insider | ― | 2,100,073 | |
| 1,980,074 | Insider | ― | 105,537,944 | |
| 10,465 | Insider | ― | 557,785 | |
| 36,273 | Insider | ― | 1,933,351 | |
| 2,975,072 | Insider | ― | 158,571,338 | |
| 2,549,735 | Insider | ― | 135,900,876 | |
| 247,700 | Insider | ― | 13,202,410 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 363,161 | Institution | ― | 19,356,481 | |
| 4,194 | Institution | ― | 223,540 | |
| 2,752 | Institution | ― | 146,682 | |
| 37,265 | Institution | ― | 1,986,225 | |
| 7,430 | Institution | ― | 396,019 | |
| 18,186 | Institution | ― | 969,314 | |
| 11,253 | Institution | ― | 599,785 | |
| 3,225 | Institution | ― | 171,893 | |
| 126,311 | Institution | ― | 6,732,376 | |
| 5,382 | Institution | ― | 286,861 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Mirati Therapeutics (DE:26M)?
According to the latest TipRanks data, approximately 0.49% of the company's stock is held by institutional investors, 0.00% is held by insiders, and 99.51% is held by retail investors.
What percentage of Mirati Therapeutics (DE:26M) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.49% of Mirati Therapeutics (DE:26M) stock is held by institutional investors.
What percentage of Mirati Therapeutics (DE:26M) stock is held by retail investors?
According to the latest TipRanks data, approximately 99.51% of Mirati Therapeutics (DE:26M) stock is held by retail investors.
Who owns the most shares of Mirati Therapeutics (DE:26M)?
Orbimed Advisors Llc owns the most shares of Mirati Therapeutics (DE:26M).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.